Why rare-disease drugs could become India’s next pharma frontier
Since India has already shown the world how to make drugs affordable, the next challenge is to show the world how to make rare-disease drugs accessible; with a streamlined regulatory pathway, appropriate financial incentives, and government procurement, India could build a globally competitive rare-disease pharmaceutical sector
We haven't written up this one. The Hindu Health has the full story — the link below goes straight to it.
